Evolution of the Average Target: Adimmune Corporation

Evolution of the Average Target - Adimmune Corporation

Evolution of the Target Price: Adimmune Corporation

Evolution of the Target Price - Adimmune Corporation

Changes in Analyst Recommendations: Adimmune Corporation

ab0ac2b30ad.6hFduc_EnFs5HU_up3wduDtjvxNlNDw6OvH1v3faGb0.p1klgOKQqj5PTCaC5SpV4gpUy2E2DFUNbJzGjRuyU8-faBf8hLzmClhVPA~966df4913cf9b4ca46f8500ae598c796

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +22.09%
-0.98%
+2.27%
-1.51%
-2.72%
+6.9%
-5.37%
+12.6%
-14.74%
+0.12%
Average +1.87%
Weighted average by Cap. -0.17%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
17.20TWD
Average target price
21.00TWD
Spread / Average Target
+22.09%
High Price Target
21.00TWD
Spread / Highest target
+22.09%
Low Price Target
21.00TWD
Spread / Lowest Target
+22.09%

Analyst Consensus Detail

Analyst consensus - Adimmune Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Adimmune Corporation
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Adimmune Corporation
  1. Stock Market
  2. Stocks
  3. 4142 Stock
  4. Consensus Adimmune Corporation